- Home
- ERNA vs BFRI Comparison
ERNA vs BFRI Comparison
Compare ERNA & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERNA
- BFRI
- Stock Information
- Founded
- ERNA 2018
- BFRI 1997
- Country
- ERNA United States
- BFRI United States
- Employees
- ERNA N/A
- BFRI N/A
- Industry
- ERNA Biotechnology: Pharmaceutical Preparations
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- ERNA Health Care
- BFRI Health Care
- Exchange
- ERNA Nasdaq
- BFRI Nasdaq
- Market Cap
- ERNA 10.2M
- BFRI 10.8M
- IPO Year
- ERNA N/A
- BFRI 2021
- Fundamental
- Price
- ERNA $1.29
- BFRI $0.96
- Analyst Decision
- ERNA
- BFRI Strong Buy
- Analyst Count
- ERNA 0
- BFRI 1
- Target Price
- ERNA N/A
- BFRI $2.75
- AVG Volume (30 Days)
- ERNA 162.4K
- BFRI 97.3K
- Earning Date
- ERNA 11-11-2025
- BFRI 11-12-2025
- Dividend Yield
- ERNA N/A
- BFRI N/A
- EPS Growth
- ERNA N/A
- BFRI N/A
- EPS
- ERNA N/A
- BFRI N/A
- Revenue
- ERNA $488,000.00
- BFRI $39,188,000.00
- Revenue This Year
- ERNA N/A
- BFRI $9.70
- Revenue Next Year
- ERNA N/A
- BFRI $12.58
- P/E Ratio
- ERNA N/A
- BFRI N/A
- Revenue Growth
- ERNA 201.24
- BFRI 11.20
- 52 Week Low
- ERNA $1.09
- BFRI $0.54
- 52 Week High
- ERNA $18.75
- BFRI $2.22
- Technical
- Relative Strength Index (RSI)
- ERNA 49.69
- BFRI 46.87
- Support Level
- ERNA $1.25
- BFRI $0.93
- Resistance Level
- ERNA $1.38
- BFRI $1.09
- Average True Range (ATR)
- ERNA 0.08
- BFRI 0.05
- MACD
- ERNA 0.02
- BFRI -0.01
- Stochastic Oscillator
- ERNA 63.47
- BFRI 21.58
About ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.